Asset Management One Co. Ltd. Increases Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Asset Management One Co. Ltd. raised its position in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 7.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 73,712 shares of the medical research company's stock after buying an additional 4,963 shares during the period. Asset Management One Co. Ltd.'s holdings in IQVIA were worth $12,995,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. American National Bank & Trust purchased a new position in shares of IQVIA in the 1st quarter valued at about $26,000. ST Germain D J Co. Inc. increased its position in shares of IQVIA by 66.1% in the first quarter. ST Germain D J Co. Inc. now owns 191 shares of the medical research company's stock valued at $34,000 after buying an additional 76 shares in the last quarter. GKV Capital Management Co. Inc. acquired a new position in shares of IQVIA during the 4th quarter worth approximately $39,000. Lee Danner & Bass Inc. purchased a new position in shares of IQVIA during the 4th quarter valued at approximately $44,000. Finally, Zions Bancorporation N.A. grew its stake in IQVIA by 55.2% in the 4th quarter. Zions Bancorporation N.A. now owns 239 shares of the medical research company's stock valued at $47,000 after acquiring an additional 85 shares during the period. Institutional investors and hedge funds own 89.62% of the company's stock.

IQVIA Stock Down 0.4%

Shares of NYSE IQV opened at $158.00 on Friday. The company has a market capitalization of $27.33 billion, a P/E ratio of 21.53, a P/E/G ratio of 1.74 and a beta of 1.28. The company has a debt-to-equity ratio of 2.19, a current ratio of 0.82 and a quick ratio of 0.82. The company has a 50 day simple moving average of $148.98 and a 200-day simple moving average of $174.85. IQVIA Holdings Inc. has a 1 year low of $134.65 and a 1 year high of $252.88.

IQVIA (NYSE:IQV - Get Free Report) last posted its earnings results on Tuesday, May 6th. The medical research company reported $2.70 EPS for the quarter, beating analysts' consensus estimates of $2.63 by $0.07. The company had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.77 billion. IQVIA had a return on equity of 29.16% and a net margin of 8.61%. The company's revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.54 earnings per share. On average, equities research analysts predict that IQVIA Holdings Inc. will post 10.84 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. Robert W. Baird decreased their price objective on shares of IQVIA from $195.00 to $161.00 and set a "neutral" rating on the stock in a report on Wednesday, May 7th. HSBC lowered shares of IQVIA from a "buy" rating to a "hold" rating and decreased their price target for the company from $260.00 to $160.00 in a research note on Friday, April 25th. Hsbc Global Res lowered IQVIA from a "strong-buy" rating to a "hold" rating in a research note on Friday, April 25th. Redburn Partners set a $188.00 target price on IQVIA in a report on Friday, May 23rd. Finally, Truist Financial lowered their price target on IQVIA from $263.00 to $216.00 and set a "buy" rating on the stock in a research note on Thursday, April 10th. Eight equities research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, IQVIA currently has an average rating of "Moderate Buy" and an average price target of $226.32.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.